Cairn Biosciences is developing next-generation therapeutics that address significant challenges in the treatment of serious diseases.
Cairn Biosciences is developing next-generation therapeutics that address significant challenges in the treatment of serious diseases.Cairn’s drug discovery engine addresses the profound unmet need for new tools to decipher cellular complexity and enable scalable discovery of groundbreaking therapies. The company's proprietary approach enables us to monitor multiple dynamic facets of previously inaccessible biology in live cells and fast-track the discovery of a pipeline of drugs for a wide range of indications with an initial focus on cancer.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Aug 9, 2016 | Grant | $0.90M | 1 | National Science Foundation | — | Detail |
Dec 8, 2014 | Grant | $150K | 1 | National Science Foundation | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
National Science Foundation | Yes | Grant |